A recent study found that breast cancer–specific survival in patients with invasive lobular carcinoma was inferior compared to patients with invasive ductal carcinoma. A recent study found that breast ...

Rates of one type of breast cancer — invasive lobular carcinoma — have been rising in the United States more than three times faster than those of all other breast cancers combined over the past ...

While the ductal subtype accounts for 70% to 80% of all breast cancers and the lobular subtype accounts for just 10% to 15%, the lobular subtype is more common among peri- and postmenopausal women, is ...

It’s taken a few years, but lobular breast cancer has finally made its way into the research spotlight. The second-most common type of breast cancer after ductal or NST (no specific type), invasive ...

Lobular breast cancer rates increased 2.8 percent per year over the past decade, compared with a 0.8 percent annual increase for all other breast cancers. Lobular breast cancer grows in a linear ...

The SNMMI Mars Shot Research Fund is pleased to announce that Randy Yeh, MD, a radiologist and nuclear medicine physician at Mount Sinai Health System, associate professor of radiology, and chief of ...

During a year-in-review session at the 2022 San Antonio Breast Cancer Symposium (SABCS), a summary of presentations on lobular breast cancer described the subtype as "the Unseen." Fast forward 1 year, ...

The American Cancer Society has released a report on occurrence and outcomes in the United States for this subtype of breast cancer. Findings show an estimated 33,600 women will be diagnosed with ...

NCCN Guidelines® recommend FES PET for systemic staging in certain patients with invasive lobular cancer (ILC), which could facilitate greater diagnostic accuracy, earlier interventions, better ...